PDF(Pubmed)
Abstract：
UNASSIGNED: To evaluate and compare the prevalence and type of abdominal involvements identified on CT scans in COVID-19 critically ill patients to those observed in critically ill patients with non-SARS-CoV-2 viral pneumonia.
UNASSIGNED: Monocentric IRB approved retrospective study comparing all abdominal CT scans performed for patients admitted in the ICU with COVID-19 and those performed in a historical cohort of ICU patients with non-SARS-CoV-2 viral pneumonia. For each patient, gallbladder abnormality, acute pancreatitis signs, acute adrenal infarction, renal infarcts, bowel wall thickening and CT scan signs of bowel ischemia were assessed. Results were then compared between critically ill COVID-19 and non-COVID-19 patients (Chi-2 or Fisher exact tests for categorical data and Student t-test or Mann-Whitney U test for continuous data as appropriate).
UNASSIGNED: Ninety-nine COVID-19 patients and 45 non-COVID-19 patients were included.No difference was found between the rate of abnormal findings comparing COVID-19 patients and patients with other viral pneumonia (63/99 [64%] vs 27/45 [61%], p=0.94). Acute pancreatitis signs were more commonly seen in COVID-19 patients but without statistically difference between groups (14/99 [14%] vs 3/45 [6.7%], p=0.31). Bowel wall thickening was slightly more commonly seen in patients with other viral pneumonia (18/99 [18%] vs 11/45 [24%], p=0.52), however ischemic features were observed in higher rate in the COVID-19 group, although without reaching statistically significant differences (7/99 [7.1%] vs 2/45 [4.4%], p=0.75).
UNASSIGNED: The rate and severity of abdominal involvement demonstrated by CT in ICU patients hospitalized for COVID-19 although high were not different to that observed in patients with other severe viral pneumoniae.
UNASSIGNED: Monocentric IRB approved retrospective study comparing all abdominal CT scans performed for patients admitted in the ICU with COVID-19 and those performed in a historical cohort of ICU patients with non-SARS-CoV-2 viral pneumonia. For each patient, gallbladder abnormality, acute pancreatitis signs, acute adrenal infarction, renal infarcts, bowel wall thickening and CT scan signs of bowel ischemia were assessed. Results were then compared between critically ill COVID-19 and non-COVID-19 patients (Chi-2 or Fisher exact tests for categorical data and Student t-test or Mann-Whitney U test for continuous data as appropriate).
UNASSIGNED: Ninety-nine COVID-19 patients and 45 non-COVID-19 patients were included.No difference was found between the rate of abnormal findings comparing COVID-19 patients and patients with other viral pneumonia (63/99 [64%] vs 27/45 [61%], p=0.94). Acute pancreatitis signs were more commonly seen in COVID-19 patients but without statistically difference between groups (14/99 [14%] vs 3/45 [6.7%], p=0.31). Bowel wall thickening was slightly more commonly seen in patients with other viral pneumonia (18/99 [18%] vs 11/45 [24%], p=0.52), however ischemic features were observed in higher rate in the COVID-19 group, although without reaching statistically significant differences (7/99 [7.1%] vs 2/45 [4.4%], p=0.75).
UNASSIGNED: The rate and severity of abdominal involvement demonstrated by CT in ICU patients hospitalized for COVID-19 although high were not different to that observed in patients with other severe viral pneumoniae.
摘要：
■评估和比较COVID-19重症患者与非SARS-CoV-2病毒性肺炎的重症患者在CT扫描中发现的腹部受累的患病率和类型。
■单中心IRB批准的回顾性研究，比较了在ICU接受COVID-19的患者和在ICU非SARS-CoV-2病毒性肺炎患者的历史队列中进行的所有腹部CT扫描。对于每个病人来说,胆囊异常,急性胰腺炎体征，急性肾上腺梗死,肾梗死,评估肠壁增厚和肠缺血的CT扫描征象.然后比较重症COVID-19和非COVID-19患者的结果（分类数据的Chi-2或Fisher精确检验，连续数据的Studentt检验或曼-WhitneyU检验适当）。
■纳入99例COVID-19患者和45例非COVID-19患者。COVID-19患者和其他病毒性肺炎患者的异常发现率无差异（63/99[64%]vs27/45[61%]，p=0.94）。急性胰腺炎体征更常见于COVID-19患者，但组间无统计学差异(14/99[14%]vs3/45[6.7%]，p=0.31）。肠壁增厚在其他病毒性肺炎患者中更为常见（18/99[18%]vs11/45[24%]，p=0.52),然而，在COVID-19组中观察到较高的缺血性特征，尽管没有达到统计学上的显着差异（7/99[7.1％]vs2/45[4.4％]，p=0.75)。
■在因COVID-19住院的ICU患者中，CT显示的腹部受累的发生率和严重程度尽管很高，但与其他严重病毒性肺炎患者的发生率和严重程度没有差异。
■单中心IRB批准的回顾性研究，比较了在ICU接受COVID-19的患者和在ICU非SARS-CoV-2病毒性肺炎患者的历史队列中进行的所有腹部CT扫描。对于每个病人来说,胆囊异常,急性胰腺炎体征，急性肾上腺梗死,肾梗死,评估肠壁增厚和肠缺血的CT扫描征象.然后比较重症COVID-19和非COVID-19患者的结果（分类数据的Chi-2或Fisher精确检验，连续数据的Studentt检验或曼-WhitneyU检验适当）。
■纳入99例COVID-19患者和45例非COVID-19患者。COVID-19患者和其他病毒性肺炎患者的异常发现率无差异（63/99[64%]vs27/45[61%]，p=0.94）。急性胰腺炎体征更常见于COVID-19患者，但组间无统计学差异(14/99[14%]vs3/45[6.7%]，p=0.31）。肠壁增厚在其他病毒性肺炎患者中更为常见（18/99[18%]vs11/45[24%]，p=0.52),然而，在COVID-19组中观察到较高的缺血性特征，尽管没有达到统计学上的显着差异（7/99[7.1％]vs2/45[4.4％]，p=0.75)。
■在因COVID-19住院的ICU患者中，CT显示的腹部受累的发生率和严重程度尽管很高，但与其他严重病毒性肺炎患者的发生率和严重程度没有差异。
